Founded in 1992, Hualan Biological Engineering Inc. is a national innovation-based pilot enterprise engaging in the research, development, production, and commercialization of human blood products, vaccines, monoclonal antibody, and genetic recombination biologics. Hualan Bio was the first Chinese company whose Plasma products gained GMP certificate, the first listed company of plasma products in China, the first company manufacturing the H1N1 influenza vaccine on a global scale, and also the first Chinese manufacturer whose influenza vaccine passed WHO pre-qualification. Passing “ISO9000” (Quality), “ISO14000” (Environment) and “GBT28000” (Occupation health) management system certification, and holding a number of proprietary intellectual property rights, Hualan is branded as a well-known trademark in China. Now, Hualan Bio has more than 30 subsidiaries with industrial investment extended to Henan, Beijing, Chongqing, Jiangsu, Guangxi, Guizhou, etc. The market share and coverage rate of major products take the front rank in the industry and its products exported to Southeast Asian and Latin America. Hualan Bio is one of the largest biologics R&D and manufacturing enterprise in China.